A Study of the Safety and Tolerability of CDX-6114 in Healthy Volunteers
NCT03797664
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CDX-6114
DRUG:
Placebo
Sponsor
Codexis Inc.